{
    "Trade/Device Name(s)": [
        "Cell-ChexTM",
        "Cell-Chex T\u2122M"
    ],
    "Submitter Information": "Streck",
    "510(k) Number": "K101335",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000076"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GLQ"
    ],
    "Summary Letter Date": "July 26, 2010",
    "Summary Letter Received Date": "July 27, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.8625"
    ],
    "Regulation Name(s)": [
        "Hematology quality control mixture"
    ],
    "Analyte Class(es)": [
        "hematology",
        "misc"
    ],
    "Analyte(s)": [
        "Red Blood Cells",
        "White Blood Cells",
        "Mononuclear cells",
        "Polymorphonuclear cells",
        "Neutrophils",
        "Eosinophils",
        "Basophils",
        "Lymphocytes",
        "Monocytes",
        "Monosodium urate crystals"
    ],
    "Specimen Type(s)": [
        "Cerebrospinal fluid",
        "Pleural fluid",
        "Pericardial fluid",
        "Peritoneal fluid",
        "Synovial fluid"
    ],
    "Specimen Container(s)": [
        "Glass vial"
    ],
    "Instrument(s)/Platform(s)": [
        "Hemocytometer",
        "Cytospin\u00ae smear"
    ],
    "Method(s)/Technology(ies)": [
        "Manual cell count",
        "Microscopy"
    ],
    "Methodologies": [
        "Manual counting",
        "Cell differentiation assessment"
    ],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Streck Cell-Chex hematology control for manual monitoring of cell counts and differentiation in body fluids",
    "Indications for Use Summary": "Intended for monitoring total cell counts and white blood cell differentiation in patient body fluids using hemocytometer and Cytospin smears, and for monitoring presence of crystals in synovial fluid",
    "fda_folder": "Hematology"
}